Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
8.90
+0.14 (1.60%)
At close: Dec 5, 2025, 4:00 PM EST
9.43
+0.53 (5.96%)
After-hours: Dec 5, 2025, 7:59 PM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $481.65 million as of December 5, 2025. Its market cap has increased by 196.67% in one year.
Market Cap
481.65M
Enterprise Value
288.02M
1-Year Change
196.67%
Ranking
Category
Stock Price
$8.90
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $481.65M, an increase of 59.68%. That is a compound annual growth rate of 7.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |